PD-L1 aptamer-functionalized degradable hafnium oxide nanoparticles for near infrared-II diagnostic imaging and radiosensitization

Immune checkpoint blockade is now recognized as a paradigm-shifting cancer therapeutic strategy, whereas there remains difficulty in accurately predicting immunotherapy efficacy by PD-L1 expression. In addition, radiotherapy for cancer patients faces the problem of insufficient dose of radiotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Min, Shen, Xiao, Fan, Xueqi, Li, Jiwei, Bai, Jingwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282151/
https://www.ncbi.nlm.nih.gov/pubmed/37351473
http://dx.doi.org/10.3389/fbioe.2023.1224339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282151/
https://www.ncbi.nlm.nih.gov/pubmed/37351473
http://dx.doi.org/10.3389/fbioe.2023.1224339

Ejemplares similares